Telix Pharmaceuticals Limited
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $174.6M | $277.3M | $84.3M |
| FY2024 | $587.4M | $940.4M | $440.0M |
| FY2025 | $748.6M | $1.16B | $141.9M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $174.6M | $277.3M | $84.3M |
| FY2024 | $587.4M | $940.4M | $440.0M |
| FY2025 | $748.6M | $1.16B | $141.9M |